News & Views | Published:

DIABETES

Cell makeover for diabetes therapy

Patients with severe diabetes rely on insulin injections to control their blood glucose. A study now provides evidence that human cells that normally do not release insulin can be converted into insulin-producing cells that are able to normalize glycaemia in diabetic mice.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

  1. 1.

    Zhou, Q. & Melton, D. A. Nature 557, 351–358 (2018).

  2. 2.

    Aguayo-Mazzucato, C. & Bonner-Weir, S. Cell Metab. 27, 57–67 (2018).

  3. 3.

    Bakhti, M., Böttcher, A. & Lickert, H. Nat. Rev. Endocrinol. 15, 155–171 (2019).

  4. 4.

    Thorel, F. et al. Nature 464, 1149–1154 (2010).

  5. 5.

    Chera, S. et al. Nature 514, 503–507 (2014).

  6. 6.

    Furuyama, K. et al. Nature https://doi.org/10.1038/s41586-019-0942-8 (2019).

  7. 7.

    Matsuoka, T. A. et al. Diabetes 66, 1293–1300 (2017).

  8. 8.

    Roscioni, S. S., Migliorini, A., Gegg, M. & Lickert, H. Nat. Rev. Endocrinol. 12, 695–709 (2016).

  9. 9.

    Wang, Y. et al. Mol. Ther. 26, 1327–1342 (2018).

  10. 10.

    Dorrell, C. et al. Stem Cell Res. 1, 183–194 (2008).

Download references

Author information

Correspondence to Heiko Lickert.

Ethics declarations

Competing interests

The authors declare no competing interests.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark
Fig. 1: Reprogramming of human α-cells into β-cells.